{
  "drug_name": "Cyproheptadine",
  "url": "https://wikem.org/wiki/Cyproheptadine",
  "scraped_at": "2026-01-10T07:51:23.180921",
  "sections": {
    "Uses": {
      "text": "Treatment of serotonin syndrome",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Administration": {
      "text": "Dosage Forms: 4mg tab, 2mg/5ml solution\nRoutes of Administration: oral\nCommon Trade Names: Periactin or Peritol",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "initial dose of 12mg is recommended, followed by 2mg every two hours until clinical response is seen",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Children younger than two years can be given approximately 0.06mg/kg per dose every six hours, if needed (not to exceed 0.25mg/kg/day).\nChildren two to six years can be given 2mg every six hours, if needed (not to exceed 12mg/day).\nChildren 7 to 14 years can be given 4mg every six hours, if needed (not to exceed 16mg/day).",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: B",
      "subsections": {
        "Renal_Dosing": {
          "text": "No recommendations",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "No recommendations",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "No recommendations",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "No recommendations",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "No recommendations",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nTreatment in newborns or nursing mothers",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Hypotension",
          "tables": []
        },
        "Common": {
          "text": "Sedation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Hypotension",
      "subsections": {
        "Common": {
          "text": "Sedation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Sedation",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 1-4 hours\nMetabolism: Liver\nExcretion: Urine",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Histamine-1 receptor antagonist\n5-HT1A and 5-HT2A (seritonin) antagonistic properties\nWeak anticholinergic activity",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "References": {
      "text": "1. Boyer EW. Serotonin syndrome. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on January 11, 2016.)",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}